AI Summary
This article discusses two initiatives in South Africa that are working to combat drug-resistant tuberculosis: new drug discovery and genomic surveillance. The efforts are aimed at addressing the challenges posed by drug-resistant strains of TB in the country. Paul Adepoju provides a report on these endeavors.
Two parallel efforts in South Africa, new drug discovery and genomic surveillance, aim to address the challenge of drug-resistant tuberculosis. Paul Adepoju reports.